Techniques to Optimize the Use of Optical Coherence Tomography: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database

Kuku, 2018, Optical coherence tomography-guided percutaneous coronary intervention compared with other imaging guidance: a meta-analysis, Int J Cardiovasc Imaging, 34, 503, 10.1007/s10554-017-1272-2 Smilowitz, 2018, Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States, Catheter Cardiovasc Interv, 92, E410, 10.1002/ccd.27673 Jones, 2018, Angiography alone versus angiography plus optical coherence tomography to guide percutaneous coronary intervention: outcomes from the pan-London PCI cohort, JACC Cardiovasc Interv, 11, 1313, 10.1016/j.jcin.2018.01.274 Barlis, 2009, A multicentre evaluation of the safety of intracoronary optical coherence tomography, EuroIntervention, 5, 90, 10.4244/EIJV5I1A14 Takarada, 2010, Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion, Catheter Cardiovasc Interv, 75, 202, 10.1002/ccd.22273 Lehtinen, 2013, Feasibility and safety of frequency-domain optical coherence tomography for coronary artery evaluation: a single-center study, Int J Cardiovasc Imaging, 29, 997, 10.1007/s10554-013-0196-8 Manufacturer and User Facility Device Experience (MAUDE) database: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm [accessed August 28, 2018]. FDA ILUMIEN OPTIS with DF OPTIS Catheter 510(k) Summary and IFU response. https://www.accessdata.fda.gov/cdrh_docs/pdf14/K141453.pdf [accessed September 4, 2018]. Ensign LG, Cohen KB. A Primer to the Structure, Content and Linkage of the FDA's Manufacturer and User Facility Device Experience (MAUDE) Files. EGEMS (Wash DC). 2017 Jun 14;5(1):12. Khalid, 2019 Chen, 2019, Adverse events associated with the use of guide extension catheters during percutaneous coronary intervention: reports from the manufacturer and user facility device experience (MAUDE) database, Cardiovasc Revasc Med, 10.1016/j.carrev.2019.02.016 Omar, 2016, Review: stent fracture in the drug-eluting stent era, Cardiovasc Revasc Med, 17, 404, 10.1016/j.carrev.2016.06.002 Nebeker, 2006, Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project, J Am Coll Cardiol, 47, 175, 10.1016/j.jacc.2005.07.071 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K141453 [accessed October 1, 2018]. Koyama, 2014, Periprocedural myocardial injury and right bundle branch block during coronary optical coherence tomography in an acute coronary syndrome patient with severe coronary ectasia, Int J Cardiol, 177, 1113, 10.1016/j.ijcard.2014.08.082 Imola, 2010, Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention, EuroIntervention, 6, 575, 10.4244/EIJV6I5A97 van der Sijde, 2017, Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound, Eur Heart J Cardiovasc Imaging, 18, 467 Ulrich, 2017, Safety of optical coherence tomography in pediatric heart transplant patients, Int J Cardiol, 228, 205, 10.1016/j.ijcard.2016.11.109 Ali, 2016, Stone GW; ILUMIEN III: OPTIMIZE PCI investigators. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial, Lancet, 388, 2618, 10.1016/S0140-6736(16)31922-5 Kubo, 2017, Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results, Eur Heart J, 38, 3139, 10.1093/eurheartj/ehx351 Rao, 2008, Postmarket evaluation of breakthrough technologies, Am Heart J, 156, 201, 10.1016/j.ahj.2008.01.036 Al-Lamee, 2018, Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial, Lancet, 391, 31, 10.1016/S0140-6736(17)32714-9 OPTIS™ Software Instructions for Use Version E.4.1 Released Date: 2017.01.18. https://manuals.sjm.com/Search-Form?re=North-America&cc=US&ln=EN&fam=01246feb-5d00-407c-8f4c-f86b3d1ae677&cat=4733416f-6baa-4967-9680-f546d6cacd26&seg=5b42b09e-941f-418b-a8da-621d741b012b&ipp=10 [accessed September 4, 2018]. Fujino, 2018, A new optical coherence tomography-based calcium scoring system to predict stent underexpansion, EuroIntervention, 13, e2182, 10.4244/EIJ-D-17-00962 Shlofmitz, 2018, Algorithmic approach for optical coherence tomography-guided stent implantation during percutaneous coronary intervention, Interv Cardiol Clin, 7, 329 Räber, 2018, Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions, EuroIntervention, 14, 656, 10.4244/EIJY18M06_01 Tearney, 2012, J Am Coll Cardiol, 59, 1058, 10.1016/j.jacc.2011.09.079